Enroflon foaming 32 tablets

DESCRIPTION

Enroflon foaming tablets are used for the prevention and treatment of inflammatory processes in the uterus after obstetrics, operative separation of the placenta, abortion, with complicated and pathological childbirth, with acute postpartum endometritis in cattle and pigs. In appearance, it is an oblong tablet with rounded edges and a smooth uniform surface, dry solid consistency from light gray to gray-yellow color.

COMPOSITION

An antibacterial drug containing enrofloxacin as an active ingredient (0.36 g in each tablet).

PHARMACHOLOGIC EFFECT

Enrofloxacin, which is a part of foaming tablets, has a wide spectrum of antibacterial action, inhibits the growth and development of gram-positive and gram-negative microorganisms, including E. coli, Haemophilus, Klebsiella, Pasteurella, Pseudomonas, Bordetella, Campylobacter, Erysbaclopotcion, C Actinobacillus Clostridium, Bacteroides, Fusobacterium, and Mycoplasma spp. Bacterial resistance to enroflon develops relatively slowly, since the mechanism of the antimicrobial action of enrofloxacin is associated with inhibition of the activity of the enzyme gyrase, which affects the replication of the DNA helix in the bacterial cell. Due to the foaming base, enrofloxacin is evenly distributed over the uterine lining. The released carbon dioxide enhances the resorption of the drug,

INDICATIONS

Prevention and treatment of inflammatory processes in the uterus after obstetric aid of the surgical department of the placenta, abortions, with complicated and pathological childbirth, with acute postpartum endometritis.

APPLICATION AND DOSAGE

For prophylactic purposes, enroflon is administered once, one tablet at a time, immediately after the separation of the placenta, abortion, or assistance in complicated and pathological childbirth. For therapeutic purposes, the drug is administered in a dose of 1 2 tablets with an interval of 24 hours 2 - 3 times until clinical recovery. The tablets are injected into the cervix by hand, wearing a disposable plastic glove, or using a forceps, and pushed into the uterine cavity.

SIDE EFFECTS

Not observed in recommended doses.

CONTRAINDICATIONS

Not installed.

SPECIAL INSTRUCTIONS

Milk obtained from cows during treatment and within 72 hours after the last application of the drug is used in animal feed after boiling. Slaughter of animals for meat and the use of milk for food purposes is allowed 72 hours after the last use of the drug. The meat of animals that were forcedly killed before the expiration of the specified period is used as feed for carnivores or for the production of meat and bone meal.

SHELF LIFE AND STORAGE

List B. In a dry, dark place at a temperature not exceeding 25? C. The shelf life is 3 years.

PACKAGING

Available in boxes of 32 tablets.

Specifications

KolVUP

4

Manufacturer

VIC

Temperature regime

from +2 to +25

Teaser

prevention and treatment of inflammatory processes in the uterus after obstetrics, surgical separation of the placenta, abortions, with complicated and pathological childbirth, with acute postpartum endometritis